Page last updated: 2024-10-23

azathioprine and Angiomatosis

azathioprine has been researched along with Angiomatosis in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Angiomatosis: A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LeBoit, PE1
Solomon, AR1
Santa Cruz, DJ1
Wick, MR1

Other Studies

1 other study available for azathioprine and Angiomatosis

ArticleYear
Angiomatosis with luminal cryoprotein deposition.
    Journal of the American Academy of Dermatology, 1992, Volume: 27, Issue:6 Pt 1

    Topics: Aged; Angiomatosis; Azathioprine; Cryoglobulins; Humans; Immunoenzyme Techniques; Male; Middle Aged;

1992